BioCentury
ARTICLE | Clinical News

BPN14770: Phase I started

January 18, 2016 8:00 AM UTC

Tetra began a double-blind, placebo-controlled, U.S. Phase I trial to evaluate single ascending doses of oral BPN14770 in about 48 healthy volunteers. ...